Total Funding
14
Total FundingSeries B raised
Growth Score
pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
459311
SARcode Bioscience develops an antigen for the treatment of unmet medical needs in ophthalmology, dermatology and inflammatory diseases.
Tatjana May: General CounselPast Role: AstraZeneca, General Counsel
Graham Hetherington: Chief Financial OfficerPast Role: Indivior, Non Executive Chairman
About the Company
SARcode Corporation is a private San Francisco based biopharmaceutical company engaged in the development of a novel class of small molecule lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18; αLβ2) antagonists as a topical agent for the treatment of significant unmet medical needs in ophthalmology, dermatology and other
inflammatory diseases.
